Results 341 to 350 of about 3,108,169 (356)

Melanoma: Recent Advances

2016
Venkataram Mysore, Gayatri Khatri
openaire   +1 more source

Melanoma staging: Evidence‐based changes in the American Joint Committee on Cancer eighth edition cancer staging manual

Ca-A Cancer Journal for Clinicians, 2017
Jeff Gershenwald, Richard A Scolyer, Kenneth Hess   +2 more
exaly  

Survival outcomes of patients with advanced mucosal melanoma diagnosed from 2013 to 2017 in the Netherlands – A nationwide population-based study

European Journal of Cancer, 2020
Michiel C T Van Zeijl, Mariëtte I E Van Poelgeest, Liesbeth C De Wreede   +2 more
exaly  

An Evidence-based Staging System for Cutaneous Melanoma

Ca-A Cancer Journal for Clinicians, 2004
Arthur Sober, John F Thompson, Michael B Atkins   +2 more
exaly  

Survival follow-up and ipilimumab retreatment of patients with advanced melanoma who received ipilimumab in prior phase II studies

Annals of Oncology, 2014
Bart Neyns
exaly  

Anti-PD-1 therapies—a new first-line option in advanced melanoma

Nature Reviews Clinical Oncology, 2015
Ryan J Sullivan, Keith T Flaherty
exaly  

Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2020
Ralf Gutzmer, Daniil Stroyakovskiy, Helen Gogas   +2 more
exaly  

Advanced, Unresectable Melanoma

Oncology Times, 2013
openaire   +1 more source

Reality check for nivolumab in advanced-stage melanoma

Nature Reviews Clinical Oncology, 2017
Diana Romero
exaly  

Cost Effectiveness of Pembrolizumab for Advanced Melanoma Treatment in Portugal

Value in Health, 2017
Luís Silva Miguel
exaly